Pilates for Sedentary Individuals
23 giugno 2026 aggiornato da: Rommanee Rojasavastera, Mahidol University
Efficacy of Pilates on Core Stability and Physical Fitness Among Sedentary Individuals
The global rise in physical inactivity represents an escalating public health crisis, with the proportion of insufficiently active adults projected to reach 35% by 2030.
Office workers are at the highest risk due to prolonged occupational sitting; a lifestyle factor heavily linked to various musculoskeletal disorders.
While maintaining an upright posture relies on the synergistic coordination of deep core muscles, extended sitting disrupts this muscular balance, leading to chronic postural decay.
Although Pilates is proven to improve core muscle thickness, enhance physical fitness, and alleviate low back pain, existing literature shows high variability in training durations (ranging from 6 to 16 weeks) and lacks definitive conclusions regarding its long-term, residual effects post-intervention.
Consequently, it remains unclear whether the benefits of Pilates can be sustained once the structured training stops.
Therefore, this study aimed to investigate the efficacy of Pilates on core stability and physical fitness among sedentary individuals, providing insights into sustainable exercise interventions.
Panoramica dello studio
Stato
Stato
Non ancora reclutamento
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Tipo di studio
Tipo di studio
Interventistico
Iscrizione (Stimato)
Iscrizione
34
Fase
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
Contatto studio
- Nome: Rommanee Rojasavastera, M.Sc.
- Numero di telefono: +66837830777
- Email: rommanee.roj@mahidol.ac.th
Luoghi di studio
-
-
Changwat Nakhon Pathom
-
Salaya, Changwat Nakhon Pathom, Tailandia, 73170
- Faculty of Physical Therapy, Mahidol University
-
Contatto:
- Rommanee Rojasavastera, M.Sc.
- Numero di telefono: +66837830777
- Email: rommanee.roj@mahidol.ac.th
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
No
Descrizione
Inclusion Criteria:
- Aged between 18 and 59 years.
- Had a Body Mass Index (BMI) of ≥ 23 kg/m2.
- Engaged in sedentary activities (sitting) for more than 7 hours per day.
- Passed the Physical Activity Readiness Questionnaire (PAR-Q) assessment.
- Did not currently participate in any other exercise programs or physical activities during the study period.
Exclusion Criteria:
- Had visual impairments that could not be corrected with corrective lenses or glasses.
- Had a medical history of spinal or lower extremity surgery.
- Had medical conditions or received medications that affected balance and gait, such as neurological diseases or benign paroxysmal positional vertigo (BPPV).
- Pregnant during the study period.
- Had severe pain in any part of the body (pain score ≥ 7/10).
- Inability to follow the research procedures.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Numero di armi
2
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Experimental group
Participants in the experimental group participated in a Pilates exercise program.
|
The 1-hour Pilates exercise program was supervised by an instructor.
|
|
Comparatore attivo: Control group
Participants in the control group participated in a walking exercise program.
|
The 1-hour walking exercise program was supervised by a physical therapist.
Participants walked on a treadmill, where the speed was gradually increased to achieve a moderate intensity level, maintaining their heart rates within 64% to 70% of their maximum heart rate.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Muscle thickness
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
A handheld ultrasound device was used to measure trunk muscle thickness at rest and during contraction.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Muscle strength
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
A handheld dynamometer was used to measure trunk muscle strength.
Participants were instructed to maintain a maximal voluntary contraction (MVC) for 5 seconds per trial, with a 30-second rest period between trials to minimize fatigue.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Muscle flexibility
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
The sit-and-reach test was used to measure lower back and hamstring flexibility.
Participants completed static stretching for 5 minutes before assessment.
During the assessment, participants sat with knees fully extended and feet hip-width apart against the sit-and-reach box.
They then reached forward, using their fingertips to displace the sliding scale as far as possible in a single trial.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Muscle endurance
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
The McGill Core Endurance Test was used to measure trunk muscle endurance.
Each test was conducted once, with the duration recorded using a digital stopwatch.
Timing commenced once the participant achieved the standardized starting position and ceased when they could no longer maintain the required posture.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Proprioception
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Joint Repositioning Error (JRE) was measured under both eyes-open and eyes-closed conditions to assess proprioception.
Participants began the assessment seated with their hips and knees flexed at 90°, feet positioned shoulder-width apart, and arms resting naturally at their sides.
From this baseline, they were guided into a neutral reference position-defined by full trunk extension and a flat spinal alignment-which they were instructed to memorize.
To facilitate measurement, a marker was placed at the first sacral vertebra (S1), and a laser pointer was fixed 50 cm away from this landmark.
The testing procedure required participants to perform three cycles of trunk flexion and extension before attempting to return to the neutral reference position as accurately as possible.
The JRE represented the distance between the laser beam's initial and final positions.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Balance
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
The Y-Balance Test (YBT) was used to measure dynamic balance.
Participants were instructed to reach out and push the indicator as far as possible.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Posture
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Posture was measured using the Posture-analyzing and Virtual Reconstructing (PAViR) system, which utilized an RGB-D camera for skeletal reconstruction.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Pain level
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Pain location was identified through participant interviews, while pain intensity was quantified using a 0-10 Visual Analogue Scale (VAS).
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
|
Health-Related Quality of Life
Lasso di tempo: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Health-Related Quality of Life was measured using the Thai version of the World Health Organization Quality of Life Brief (WHOQOL-BREF-THAI).
This 26-item instrument assessed four core domains: physical health, psychological health, social relationships, and environment.
Responses were scored on a Likert scale, with higher scores indicating better health status and overall QoL.
|
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
Inizio studio
1 agosto 2026
Completamento primario (Stimato)
Completamento primario
1 agosto 2027
Completamento dello studio (Stimato)
Completamento dello studio
1 dicembre 2027
Date di iscrizione allo studio
Primo inviato
Primo inviato
18 giugno 2026
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
18 giugno 2026
Primo Inserito (Effettivo)
Primo Inserito
24 giugno 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
26 giugno 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
23 giugno 2026
Ultimo verificato
Ultimo verificato
1 giugno 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- MU-CIRB 2026/290.0705
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
SÌ
Descrizione del piano IPD
Research data will be shared in a de-identified format only; for instance, participant names will be replaced with codes, and faces will be blurred in all images.
Tipo di informazioni di supporto alla condivisione IPD
- RSI
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .